Pharmaceuticals (44) | Agency Agreements (44)
Browse by Company
-
Acreage Holdings, Inc. (1)
-
Adamis Pharmaceuticals Corp (1)
-
ADIAL PHARMACEUTICALS, INC. (2)
-
Ampio Pharmaceuticals, Inc. (1)
-
APRICUS BIOSCIENCES, INC. (2)
-
Aquestive Therapeutics, Inc. (1)
-
Assertio Holdings, Inc. (2)
-
AYTU BIOSCIENCE, INC (1)
-
BioPharmX Corp (1)
-
BODY & MIND INC. (3)
-
Clever Leaves Holdings Inc. (1)
-
Cocrystal Pharma, Inc. (1)
-
ContraVir Pharmaceuticals, Inc. (2)
-
IntelGenx Technologies Corp. (2)
-
Iterum Therapeutics plc (2)
-
Jaguar Health, Inc. (3)
-
Lipocine Inc. (2)
-
Neuralstem, Inc. (1)
-
NovaBay Pharmaceuticals, Inc. (1)
-
PLx Pharma Inc. (1)
-
Sonoma Pharmaceuticals, Inc. (1)
-
Stem Holdings, Inc. (1)
-
Target Group Inc. (1)
-
TITAN PHARMACEUTICALS INC (5)
-
Vallon Pharmaceuticals, Inc. (1)
-
Zomedica Pharmaceuticals Corp. (4)
Recent Contracts
-
Placement Agency Agreement dated June 6, 2022, between Aquestive Therapeutics, Inc. and A.G.P./Alliance Global Partners
(Aquestive Therapeutics, Inc., Filed With SEC on June 8, 2022)
-
Placement Agency Agreement, dated May 13, 2022, between the Company and Ladenburg Thalmann & Co., Inc
(Vallon Pharmaceuticals, Inc., Filed With SEC on May 13, 2022)
-
Placement Agency Agreement, dated May 6, 2022, by and between the Company and Ladenburg Thalmann & Co. Inc
(Neuralstem, Inc., Filed With SEC on May 6, 2022)
-
Placement Agency Agreement
(ADIAL PHARMACEUTICALS, INC., Filed With SEC on February 14, 2022)
-
Placement Agency Agreement
(TITAN PHARMACEUTICALS INC, Filed With SEC on February 3, 2022)
-
Pledge Agreement between Body and Mind Inc., DEP Nevada Inc., Nevada Medical Group, LLC, and FG Agency Lending LLC, dated July 19, 2021
(BODY & MIND INC., Filed With SEC on July 23, 2021)
-
Omnibus Collateral Assignment between Body and Mind Inc., DEP Nevada Inc., Nevada Medical Group, LLC, NMG MI 1, Inc., NMG MI C1, Inc., NMG MI P1, Inc., and FG Agency Lending LLC,...
(BODY & MIND INC., Filed With SEC on July 23, 2021)
-
Placement Agency Agreement, dated April 29, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc
(Jaguar Health, Inc., Filed With SEC on April 30, 2021)
-
Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 10, 2021
(Assertio Holdings, Inc., Filed With SEC on February 12, 2021)
-
Placement Agency Agreement by and between the Company and Roth Capital Partners, LLC, dated as of February 5, 2021
(Assertio Holdings, Inc., Filed With SEC on February 9, 2021)